This invention provides a composition comprising an effective amount of (1-3),(1-4)-β-glucan derived from barley capable of enhancing efficacy of antibodies. This invention further provides the above compositions and a pharmaceutically acceptable carrier. This invention also provides a method f
This invention provides a composition comprising an effective amount of (1-3),(1-4)-β-glucan derived from barley capable of enhancing efficacy of antibodies. This invention further provides the above compositions and a pharmaceutically acceptable carrier. This invention also provides a method for treating a subject with cancer comprising administrating the above-described composition to the subject.
대표청구항▼
What is claimed is: 1. A method for enhancing the anti-tumor or anti-cancer effect of an antibody administered to a subject comprising the steps of, orally administering to said subject a glucan derived from barley in an amount effective to enhance the anti-tumor effect of a complement-activating a
What is claimed is: 1. A method for enhancing the anti-tumor or anti-cancer effect of an antibody administered to a subject comprising the steps of, orally administering to said subject a glucan derived from barley in an amount effective to enhance the anti-tumor effect of a complement-activating antibody, wherein the antibody binds to a cancer cell expressing an antigen selected from the group consisting of CD20, HER2, EGFR, GD2, and GD3, wherein the glucan is a β-glucan having a backbone consisting of β-(1,3) and β-1,4) glycosidic linkages. 2. The method of claim 1, wherein the antibody is a monoclonal antibody. 3. The method of claim 1, wherein the antibody is capable of activating antibody dependent cell-mediated cytotoxicity. 4. The method of claim 1 wherein the complement activating antibody and the glucan are administered to the subject concurrently or sequentially. 5. The method of claim 1, wherein the cancer cell is selected from the group consisting of a neuroblastoma cell, a melanoma cell, a non-Hodgkin's lymphoma cell, a Hodgkin's lymphoma cell, an Epstein-Barr related lymphoma cell, an epidermoid cancer cell, and a breast cancer cell. 6. The method of claim 1, wherein the amount of glucan administered is about >=25 mg/kg/day, five days a week for a total of 2-4 weeks. 7. The method of claim 1, wherein the subject is a mammal. 8. The method of claim 7, wherein the subject is a human. 9. A method for enhancing the anti-tumor or anti-cancer effects of an antibody administered to a subject comprising the steps of, orally administering to said subject a glucan derived from barley in an amount effective to enhance the anti-tumor effect of a complement-activating antibody, wherein the antibody binds to a cancer cell selected from the group consisting of neuroblastoma, melanoma, breast cancer, lymphoma and epidermoid cancers, wherein the glucan is a β-glucan having a backbone consisting of β-(1,3) and β-1,4) glycosidic linkages. 10. The method of claim 9, wherein the antibody is a monoclonal antibody. 11. The method of claim 9, wherein the antibody is capable of activating antibody dependent cell-mediated cytotoxicity. 12. The method of claim 9 wherein the complement activating antibody and the glucan are administered to the subject concurrently or sequentially. 13. The method of claim 9, wherein the neuroblastoma cell expresses the antigen GD2. 14. The method of claim 9, wherein the melanoma cell expresses the antigen GD3. 15. The method of claim 9, wherein the lymphoma cell expresses the antigen CD20. 16. The method of claim 15, wherein lymphoma cell is selected from the group consisting of non-Hodgkin's lymphoma, Epstein-Barr related lymphoma, and Hodgkin's lymphoma. 17. The method of claim 9, wherein the amount of glucan administered is about >=25 mg/kg/day, five days a week for a total of 2-4 weeks. 18. The method of claim 9, wherein the subject is a mammal. 19. The method of claim 18, wherein the subject is a human.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (35)
Klein Barbara K., .beta.-D-glucan topical composition.
Nikl Libor H. (Port Coquitlam CAX) Allbright Lawrence J. (Burnaby CAX), Composition and method to enhance the efficacy of a fish vaccine and to stimulate the immune system of fish.
Jamas Spiros ; Easson ; Jr. D. Davidson ; Ostroff Gary R., Enhancement of non-specific immune defenses by administration of underivatized, aqueous soluble glucans.
Bondeson Anders (Gothenburg SEX) Isaak Bernhard (Lausanne CHX) Perrenoud Andre (Nyon CHX) Tran Minh Q. (Lausanne CHX), High-performance gyrotron for production of electromagnetic millimeter or submillimeter waves.
Cheever, Martin A.; Disis, Mary L., Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated.
Williams David L. (River Ridge LA) Browder I. William (New Orleans LA) DiLuzio ; deceased Nicholas R. (late of Gretna LA by Nicholas M. DiLuzio ; legal representative), Methods and compositions for prophylactic and therapeutic treatment of infections.
Williams David L. (River Ridge LA) Browder I. William (New Orleans LA) Diluzio ; deceased Nicholas R. (late of Gretna LA by Nicholas M. Diluzio ; legal representative), Methods and compositions for prophylactic and therapeutic treatment of infections.
Robbins Ernest A. (High Ridge MO) Seeley Robert D. (Crestwood MO), Process for the prevention and reduction of elevated blood cholesterol and triglycerides levels.
Williams David L. (River Ridge LA) Browder I. William (New Orleans LA) DiLuzio ; deceased Nicholas R. (late of New Orleans LA by Nicholas M. DiLuzio ; legal representative), Soluble phosphorylated glucan: methods and compositions for treatment of neoplastic diseases.
Donzis Byron A. (#18 W. Rivercrest Houston TX 77042), Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional u.
Donzis Byron A. (#18 W. Rivercrest Houston TX 77042), Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional u.
Jamas Spiros (Boston MA) Easson ; Jr. D. Davidson (Shrewsbury MA) Ostroff Gary R. (Worcester MA), Use of aqueous soluble glucan preparations to stimulate platelet production.
Jamas Spiros ; Easson ; Jr. D. Davidson ; Ostroff Gary R., Uses for underivatized, aqueous soluble .beta.(1-3) glucan and compositions comprising same.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.